Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001214659-20-005383

Director bought 146,382 shares at $47.00 ($6,879,954)

From the SEC's structured data for this filing

Trades in this filing

Belldegrun Arie · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-04 Purchase : show line 1 in the form +40,000 $47.00 $1,880,000 40,000 I
2020-06-04 Purchase : show line 2 in the form +106,382 $47.00 $4,999,954 1,798,163 I
Open-market purchases · 146,382 sh · avg $47.00 · $6,879,954
Loading xslF345X03/marketforms-48964.xml…